Synaptic activity and connective tissue remodeling in denervated frog muscle.
Denervation of skeletal muscle results in dramatic remodeling of the cellular and molecular composition of the muscle connective tissue. This remodeling is concentrated in muscle near neuromuscular junctions and involves the accumulation of interstitial cells and several extracellular matrix molecules. Given the role of extracellular matrix in neurite outgrowth and synaptogenesis, we predict that this remodeling of the junctional connective tissue directly influences the regeneration of the neuromuscular junction. As one step toward understanding the role of this denervation-induced remodeling in synapse formation, we have begun to look for the signals that are involved in initiating the junctional accumulations of interstitial cells and matrix molecules. Here, the role of muscle inactivity as a signal was examined. The distributions of interstitial cells, fibronectin, and tenascin were determined in muscles inactivated by presynaptic blockade of muscle activity with tetrodotoxin. We found that blockade of muscle activity for up to 4 wk produced neither the junctional accumulation of interstitial cells nor the junctional concentrations of tenascin and fibronectin normally present in denervated frog muscle. In contrast, the muscle inactivity induced the extrajunctional appearance of two synapse-specific molecules, the acetylcholine receptor and a muscle fiber antigen, mAb 3B6. These results demonstrate that the remodeling of the junctional connective tissue in response to nerve injury is a unique response of muscle to denervation in that it is initiated by a mechanism that is independent of muscle activity. Thus connective tissue remodeling in denervated skeletal muscle may be induced by signals released from or associated with the nerve other than the evoked release of neurotransmitter.
Connor
E A
EA
Department of Biology, University of Massachusetts, Amherst 01003.
Qin
K
K
Yankelev
H
H
DeStefano
D
D
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D000941:Antigens / Q000032:analysis; D015816:Cell Adhesion Molecules, Neuronal / Q000032:analysis; D002452:Cell Count; D003238:Connective Tissue / Q000737:chemistry / Q000502:physiology; D003239:Connective Tissue Cells; D016326:Extracellular Matrix Proteins / Q000032:analysis; D005353:Fibronectins / Q000032:analysis; D008564:Membrane Potentials / Q000187:drug effects; D009121:Muscle Denervation; D018485:Muscle Fibers, Skeletal / Q000276:immunology; D018482:Muscle, Skeletal / Q000737:chemistry / Q000166:cytology / Q000294:innervation / Q000502:physiology*; D009469:Neuromuscular Junction / Q000737:chemistry / Q000166:cytology / Q000502:physiology*; D011894:Rana pipiens; D011950:Receptors, Cholinergic / Q000032:analysis; D019063:Tenascin; D013779:Tetrodotoxin / Q000494:pharmacology
D000941:Antigens; D015816:Cell Adhesion Molecules, Neuronal; D016326:Extracellular Matrix Proteins; D005353:Fibronectins; D011950:Receptors, Cholinergic; D019063:Tenascin; D013779:Tetrodotoxin; D000109:Acetylcholine